quality control laboratory used for pharmacopoeial testing of Chinese herbal materials

Pharmacopoeia Grade Chinese Herbs: What Buyers Should Verify Before Ordering

“Pharmacopoeia grade” is not a universal certification for Chinese herbs. In B2B sourcing, buyers should confirm the applicable pharmacopoeia, exact botanical material, plant part, processing status, testing scope, acceptance criteria and batch-specific evidence before accepting a pharmacopoeial compliance claim.

A statement such as “Ph. Eur. tested” is therefore not enough by itself. The important questions are what material was tested, against which requirements, using which methods, and whether the results belong to the actual shipment batch.

What Does “Pharmacopoeia Grade” Mean for Chinese Herbs?

The term “pharmacopoeia grade” is commonly used in procurement, but it should not be treated as a stand-alone international certification.

Pharmacopoeias publish monographs, methods, specifications and acceptance criteria. Whether a Chinese herbal material conforms depends on the exact material and the applicable current requirements.

For example, buyers may need to identify:

  • European Pharmacopoeia (Ph. Eur.)
  • Chinese Pharmacopoeia (ChP)
  • USP–NF or other applicable USP standards
  • Japanese Pharmacopoeia (JP)
  • another national pharmacopoeia
  • a buyer-specific specification

A batch may be tested using one pharmacopoeial method without having been assessed against every requirement applicable to the material.

For this reason, a better procurement question is not:

“Is this pharmacopoeia grade?”

It is:

“Which pharmacopoeia and monograph apply, and what batch evidence shows that the supplied material meets the agreed requirements?”

Buyers qualifying a new Chinese herbal supplier should also review the supplier’s quality system, testing capability and documentation process before relying on a compliance statement.


Start With the Exact Herbal Material

cross-section slices of a dried Chinese herbal root used to confirm botanical identity and plant part

A common herb name is not a complete purchasing specification.

Before discussing pharmacopoeial compliance, define exactly what is being purchased.

Botanical identity

Confirm:

  • Latin botanical name
  • accepted species
  • Chinese name or pinyin where useful
  • plant part
  • origin where required
  • applicable pharmacopoeial material name

Different pharmacopoeias may not define apparently similar herbal materials in exactly the same way.

Plant part

Root, rhizome, bark, leaf, flower, fruit and seed are not interchangeable descriptions.

The specified plant part should match the material defined by the applicable monograph or buyer specification.

Material form

Also state whether the order is for:

  • whole raw herb
  • cleaned herb
  • cut or sliced herbal material
  • processed decoction pieces
  • powder
  • granules
  • extract
  • another preparation

Processing can change the appropriate specification, identification approach and testing requirements.

A buyer should therefore confirm the product definition before requesting a quotation or laboratory test. Product form and cut requirements are covered in the Chinese herbal slices specification guide.


Specify Which Pharmacopoeia Applies

comparison of pharmacopoeia standards applied to Chinese herbal materials

“Pharmacopoeial” is incomplete unless the applicable standard is named.

The major pharmacopoeias can differ in accepted botanical sources, plant parts, processing definitions, analytical methods, assays and acceptance criteria.

StandardWhat the buyer should confirm
European Pharmacopoeia (Ph. Eur.)Exact applicable monograph and the text currently in force
Chinese Pharmacopoeia (ChP)Current Chinese monograph, material definition and processing requirements
USP / USP–NFWhether an applicable monograph or standard exists for the material and intended use
Japanese Pharmacopoeia (JP)Applicable crude-drug monograph and current requirements for Japan/Kampo projects
Buyer specificationAdditional contractual requirements based on product, market and risk

The Chinese Pharmacopoeia 2025 edition has been in force since 1 October 2025. Under NMPA Announcement No. 32 of 2025, where a registered drug standard has fewer test items or lower limits than the pharmacopoeia, the pharmacopoeia provisions prevail; where the registered standard is stricter, both must be met. JP19 was published on 10 April 2026. Buyers should still verify the exact current monograph rather than assuming that the same herb is defined identically across different pharmacopoeias.

Most importantly:

ChP conformity does not automatically establish Ph. Eur., USP or JP conformity.

The standards need to be compared material by material.


Herb-Specific Monographs and General Requirements Are Different

A pharmacopoeial assessment may involve more than one type of requirement.

Herb-specific monograph

A specific monograph may define:

  • accepted botanical source
  • plant part
  • identification
  • purity tests
  • assay or marker compounds
  • material-specific limits

General monograph or general chapter

General requirements may describe broader quality expectations or analytical methods that apply when relevant.

Buyer specification

The buyer may add requirements based on:

  • intended product
  • destination market
  • customer quality system
  • contaminant risk
  • processing status
  • previous batch performance

These layers should be reviewed together.

A supplier should not assume that performing one pharmacopoeial test means the entire material conforms to the pharmacopoeia.


What Testing Scope Should Buyers Review?

laboratory analyst running instrument testing on Chinese herbal samples

There is no single universal laboratory panel that applies to every Chinese herb.

The required scope depends on the herb, applicable monograph, intended use, market and buyer specification.

Verification areaWhat the buyer should check
Botanical identityCorrect species, plant part and identification method
Physical conditionAppearance and foreign matter where applicable
MoistureApplicable method, limit and batch result
AshTotal ash or acid-insoluble ash where required
PesticidesAnalyte list, methods, LOQs and applicable limits
Elemental impuritiesWhich elements were tested and against which limits
MycotoxinsAflatoxins or other mycotoxins where relevant
MicrobiologyTests and limits appropriate to the material and intended use
Marker / assayApplicable marker, method and acceptance range
Sulfur dioxideWhere sulfur treatment or SO₂ is a relevant requirement
Batch identityWhether the analytical results belong to the shipment lot

Pesticides

A statement such as “pesticide tested” provides little useful information unless the buyer knows the pesticide panel, analytical method, reporting limits and acceptance criteria.

Destination-market requirements may also differ from pharmacopoeial requirements.

Pesticide & Heavy Metals Testing

Elemental impurities

The commercial phrase “heavy metals” can also be too broad.

Buyers should identify which elements are included, the method used, applicable limits and actual results.

Mycotoxins and microbiology

Aflatoxin and microbiological testing may be important for some materials and uses, but they should not be presented as universally mandatory for every herb.

The correct question is:

Which tests and limits apply to this particular material and intended use?


Do Not Confuse Ph. Eur. Testing With EU Market Compliance

This distinction is especially important for European buyers.

European Pharmacopoeia requirements concern pharmaceutical quality standards for materials within their scope. They should not be confused with every other requirement that may apply to a product entering or being marketed in Europe.

Depending on the project, separate requirements may arise from:

  • food legislation
  • food-supplement rules
  • pesticide MRL legislation
  • contaminant legislation
  • medicinal-product requirements
  • national requirements
  • buyer specifications
  • final-product classification

EMA also distinguishes EU herbal monographs, which address medicinal use and safety information, from European Pharmacopoeia monographs, which address quality requirements.

Therefore:

“Tested according to Ph. Eur.” does not automatically mean “EU compliant.”

The intended use and regulatory classification of the finished product still need to be evaluated separately.

For pharmaceutical sourcing projects, buyers can review Aile Herb’s supply and documentation workflow for pharmaceutical companies.


A COA Should Be Batch-Specific

batch certificate of analysis showing test parameters, methods and results for a Chinese herbal material

A Certificate of Analysis is an important document, but buyers should review what it actually proves.

A useful batch COA should normally identify information such as:

  • product name
  • botanical name
  • plant part
  • batch or lot number
  • relevant specification
  • test parameters
  • methods or method references
  • acceptance limits
  • results
  • units
  • approval or issue date

A generic or historical sample COA can show the document format. It does not prove that the shipment batch meets the same results.

Where detailed analytical evidence matters, buyers may also request underlying laboratory reports. Field-by-field review is covered in the Chinese herb COA guide.

Review the Test Report, Not Only the Word “Pass”

A test report should allow the buyer to understand what was actually analysed.

For critical parameters, check:

  • laboratory identity
  • sample or batch number
  • sample receipt and test dates
  • test method
  • analyte list
  • reporting limit or LOQ where relevant
  • specification limit
  • measured result
  • units

A result marked simply as “Pass” can be difficult to evaluate if the test method and acceptance criterion are not stated.

The report should also be matched to the actual shipment batch. For a field-level walkthrough of pesticide and heavy metal reports, see how to read Chinese herb test reports.

Laboratory Capability Should Match the Testing Requirement

Laboratory capability is another part of supplier qualification.

Buyers may want to confirm:

  • available analytical equipment
  • test methods
  • whether testing is in-house or outsourced
  • laboratory competence
  • accreditation where relevant
  • accreditation scope
  • third-party laboratory options

A laboratory certificate or accreditation logo should not be treated as proof that every possible test is within scope.

For critical tests, confirm the applicable method, material matrix and reporting scope. Aile Herb’s own testing scope is described on the in-house laboratory page.

Documents to Request Before Ordering

For quality-sensitive or pharmacopoeial projects, buyers should define the documentation package before production.

A practical request may include:

  1. Product specification
  2. Latin botanical name and accepted species
  3. Plant part
  4. Processing status
  5. Applicable pharmacopoeia and monograph
  6. Representative sample
  7. Processing declaration
  8. Batch-specific COA
  9. Detailed test reports where required
  10. Test methods and limits
  11. Traceability records
  12. Packaging specification
  13. Change-notification requirements

The exact package should be confirmed per product and order.

Do not assume that every supplier document is included automatically with a standard quotation.


A Practical Pharmacopoeial Batch Approval Workflow

flowchart of the batch approval workflow for pharmacopoeial Chinese herb sourcing

A controlled sourcing project can follow this sequence:

1. Define the buyer specification

Confirm botanical identity, plant part, processing status, destination market and intended use.

2. Confirm the applicable pharmacopoeia

Identify the exact standard and applicable current monograph.

3. Review a representative sample

Evaluate appearance, cut, physical condition and preliminary documentation.

4. Confirm the testing scope

Map pharmacopoeial requirements together with buyer and destination-market requirements.

5. Produce or select the commercial batch

The batch intended for shipment should be clearly identified.

6. Test the batch

Arrange the agreed analytical scope.

7. Review the COA and supporting reports

Check methods, limits, results and batch numbers.

8. Approve the shipment

Release the shipment after the agreed quality and documentation review is complete.

In short:

Buyer specification → sample review → applicable pharmacopoeia → testing scope → batch testing → document review → shipment approval

This process is stronger than relying on a supplier’s generic “pharmacopoeia grade” statement.


Final Buyer Checklist

Before ordering pharmacopoeia grade Chinese herbs, confirm:

  • Exact botanical species
  • Correct plant part
  • Raw or processed material status
  • Applicable pharmacopoeia
  • Exact current monograph
  • Required identification tests
  • Required contaminant and analytical scope
  • Test methods and acceptance limits
  • Representative sample
  • Shipment-batch COA
  • Supporting test reports where required
  • Batch traceability
  • Packaging requirements
  • Change-notification requirements

If any of these points remain unclear, resolve them before the batch is produced or released.


Can Aile Herb Supply Chinese Herbs to Pharmacopoeial Specifications?

Aile Herb works with international B2B buyers to review herbal-material specifications, processing requirements, testing scope, packaging and batch documentation.

Pharmacopoeial requirements are reviewed by product and project. We do not treat “pharmacopoeia grade” as a blanket claim across the entire herbal catalogue.

For a new enquiry, provide:

  • herb list
  • Latin name where available
  • required plant part
  • product form
  • applicable pharmacopoeia
  • destination market
  • required testing scope
  • expected order quantity

The applicable material, testing and documentation scope can then be reviewed before quotation.


FAQ

Is “pharmacopoeia grade” an official certification?

Not as a universal category for Chinese herbs. Buyers should identify the applicable pharmacopoeia, monograph, material definition, test requirements and batch evidence rather than rely on the grade label alone.

What should “Chinese Pharmacopoeia grade” mean on a 2025 purchase order? It should mean the batch complies with the Ch.P. 2025 monograph for that exact herb, in force since 1 October 2025, backed by a batch-specific COA that names the edition and shows actual results against the monograph limits. Where a supplier’s registered standard is less strict than the pharmacopoeia, NMPA rules say the pharmacopoeia prevails.

Does a COA prove that a Chinese herb complies with Ph. Eur.?

Not automatically. The COA must relate to the correct batch and should be reviewed against the applicable material definition, monograph, tests, methods and acceptance criteria.

Are Chinese Pharmacopoeia and European Pharmacopoeia standards equivalent?

No automatic equivalence should be assumed. Accepted species, plant part, processing definition, test methods and limits can differ. Buyers should compare the relevant monographs directly.

Does every Chinese herb have a European Pharmacopoeia monograph?

No. Applicability must be checked for the specific herb and material form using the current European Pharmacopoeia.

Does Ph. Eur. compliance mean a herb can automatically be sold in the EU?

No. Pharmacopoeial quality requirements are only one part of product qualification. Food, supplement, medicinal-product, national and other destination-market requirements may apply separately.

Do all herbs require pesticide, heavy-metal, aflatoxin and microbiological testing?

Not necessarily in the same scope. Testing should be determined from the applicable monograph, product risk, intended use, destination market and buyer specification.

Can testing be arranged for a specific buyer specification?

Testing scope can be reviewed against the confirmed product, specification and order requirements. The required parameters, methods, limits, laboratory and reporting scope should be agreed before testing is arranged.


Send Your Pharmacopoeial Requirements for Review

Send your herb list, applicable pharmacopoeia, destination market and required testing scope.

For herbs supplied against a pharmacopoeial monograph with the matching test scope and batch documents, see our page for pharmaceutical and Kampo manufacturers and send your herb list and applicable pharmacopoeia.